American Journal of Cardiology
Volume 83, Issue 5, Supplement 2 , Pages 143-150 , 11 March 1999

Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia

  • Christoph Stellbrink, MD

      Affiliations

    • Department of Cardiology and Internal Medicine, University of Technology, Aachen, Germany
    • Corresponding Author InformationAddress for reprints: Christoph Stellbrink, MD, Medizinische Klinik I, Universitätsklinikum der RWTH Aachen, Pauwelsstr. 30, D-52072 Aachen, Germany
    • ,
  • Angelo Auricchio, MD

      Affiliations

    • Department of Cardiology and Internal Medicine, Otto Guericke Universität, Magdeburg, Germany
    • ,
  • Björn Diem, MD

      Affiliations

    • Department of Cardiology and Internal Medicine, University of Technology, Aachen, Germany
    • ,
  • Ole-Alexander Breithardt, MD

      Affiliations

    • Department of Cardiology and Internal Medicine, University of Technology, Aachen, Germany
    • ,
  • Michael Kloss, MD

      Affiliations

    • Department of Cardiology and Internal Medicine, Otto Guericke Universität, Magdeburg, Germany
    • ,
  • Friedrich A. Schöndube, MD, PhD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, University of Technology, Aachen, Germany
    • ,
  • Helmut Klein, MD

      Affiliations

    • Department of Cardiology and Internal Medicine, Otto Guericke Universität, Magdeburg, Germany
    • ,
  • Bruno J. Messmer, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, University of Technology, Aachen, Germany
    • ,
  • Peter Hanrath, MD

      Affiliations

    • Department of Cardiology and Internal Medicine, University of Technology, Aachen, Germany

References 

  1. Eriksson H. Heart failure (a growing public health problem). J Intern Med. 1995;237:135–141
  2. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure (the Framingham study). J Am Coll Cardiol. 1993;22(suppl A):6A–13A
  3. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1991;121:951–957
  4. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, et al. The epidemiology of heart failure. Eur Heart J. 1997;18:208–225
  5. O’Connell JB, Bristow MR. Economic impact of heart failure in the United States (time for a different approach). J Heart Lung Transplant. 1993;13:S107–S112
  6. PATH-CHF investigators Auricchio A, Stellbrink C, Block M, Mortensen P. Clinical and objective improvements in severe congestive heart failure patients using univentricular or biventricular pacing (preliminary results of a randomized prospective study). (Abstr.) J Am Coll Cardiol. 1998;31(2(suppl A):):31A
  7. The SOLVD Investigators . Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302
  8. Gradman A, Deedwania P, Cody R, Massie B, Pitt B, Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 1989;14:564–570
  9. Wilson JR, Schwartz JS, Sutton MS, Ferraro N, Horowitz LN, Reichek N, et al. Prognosis in heart failure (relation to hemodynamic measurements and ventricular ectopic activity). J Am Coll Cardiol. 1983;2:403–410
  10. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol. 1990;65(suppl):42I–48I
  11. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983;51:831–836
  12. Smith WM. Epidemiology of congestive heart failure. Am J Cardiol. 1985;55(suppl A):3A–8A
  13. The CONSENSUS Trial Study Group . Effects of enalapril on mortality in severe congestive heart failure (results of the Cooperative North Scandinavian Enalapril Survival Study). N Engl J Med. 1987;316:1429–1435
  14. Uretsky BF, Sheahan RG. Primary prevention of sudden cardiac death in heart failure (will the solution be shocking?). J Am Coll Cardiol. 1997;30:1589–1597
  15. Nikolic G, Bishop RL, Singh JB. Sudden death recorded during Holter monitoring. Circulation. 1982;66:218–225
  16. Savage DD, Castelli WP, Anderson SJ, Kannel WB. Sudden unexpected death during ambulatory electrocardiographic monitoring. Am J Med. 1983;74:148–152
  17. Lewis BH, Antman EM, Graboys TB. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade des pointes. J Am Coll Cardiol. 1983;2:426–436
  18. Pratt CM, Francis MJ, Luck JC, Wyndham CR, Miller RR, Quinones MA. Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation. J Am Coll Cardiol. 1983;2:789–797
  19. Panidis IP, Morganroth J. Sudden death in hospitalized patients. Cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am Coll Cardiol. 1983;2:798–805
  20. Milner PG, Platia EV, Reid PR, Griffith LS. Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest. Am J Cardiol. 1985;56:588–592
  21. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death (mechanisms of production of fatal arrhythmia on the basis of data from 157 cases). Am Heart J. 1989;117:151–159
  22. Olshausen KV, Witt T, Pop T, Treese N, Bethge KP, Meyer J. Sudden cardiac death while wearing a Holter monitor. Am J Cardiol. 1991;67:381–386
  23. Luu M, Stevenson LW, Brunken RC, Drinkwater DC, Schelbert HR, Tillisch JH. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675–1680
  24. Birgersdotter-Green U, Rosenqvist M, Ryden L. Effect of congestive heart failure treatment on incidence and prognosis of ventricular tachyarrhythmias. J Cardiovasc Pharmacol. 1991;17(suppl 6):S53–S58
  25. Bigger JT, Flesiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250–258
  26. Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, et al. Mode of death in idiopathic dilated cardiomyopathy (a multivariate analyis of prognostic determinants). Am Heart J. 1988;116:1455–1461
  27. Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. Circulation. 1996;94:3198–3203
  28. PROVED investigator group Uretsky BF, Young JB, Shahidi E, Yellen LG, Harrison MC, Jolly K. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure (results from the PROVED trial). J Am Coll Cardiol. 1993;22:955–962
  29. Packer M, Gheorgiade M, Young JB, Constantini PJ, Adams KF, Cody RJ, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med. 1993;329:1–7
  30. The Digitalis Investigative Group . The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525–533
  31. Patterson JH, Adams KF, Applefield MM, Corder CN, Masse BR. Oral torasemide in patients with chronic congestive heart failure (effects on body weight, edema and electrolyte excretion). Pharmacotherapy. 1994;14:514–521
  32. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction—results of the survival and ventricular enlargement study. N Engl J Med. 1992;327:669–677
  33. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators . Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;2:821–827
  34. Kober L, Torp Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with severe left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:1670–1676
  35. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after prior myocardial infarction. N Engl J Med. 1995;332:80–85
  36. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo (the Cardiac Arrhythmia Suppression Trial). N Engl J Med. 1991;324:781–788
  37. Stroke Prevention in Atrial Fibrillation Investigators Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol. 1992;20:527–532
  38. Norwegian Multicenter Study Group . Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801–807
  39. Betablocker Heart Attack Trial Research Group . A randomized trial of propanolol in patients with acute myocardial infarction: I. Mortality results. JAMA. 1981;1707–1714
  40. Gundersen T. Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. Br Heart J. 1983;50:135–139
  41. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489–497
  42. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355
  43. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz AA, Schwartz PJ, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction (EMIAT). Lancet. 1997;349:667–674
  44. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations (CAMIAT). Lancet. 1997;349:675–682
  45. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1994;344:493–498
  46. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 1995;333:77–82
  47. Amiodarone Trials Meta-Analysis Investigators . Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet. 1997;350:1417–1424
  48. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA. 1993;270:1589–1595
  49. Packer M, O’Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 1996;335:1107–1114
  50. Figulla HR, Gietzen F, Zeymer U, Raiber M, Hegselmann J, Soballa R, et al. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy (results of the diltiazem in dilated cardiomyopathy trial). Circulation. 1996;94:346–352
  51. The Antiarrhythmic Versus Implantable Defibrillator (AVID) Investigators . A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576–1583
  52. Connolly SJ, Gent M, Roberts RS, Dorian P, Green MS, Klein GJ, et al. Canadian Implantable Defibrillator Study (CIDS) (study design and organization). Am J Cardiol. 1993;72(suppl):103F–108F
  53. CASH Investigators Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 1994;127:1139–1144
  54. Moss AJ, Hall J, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–1940
  55. Kim SG, Maloney JD, Pinski SL, Choue CW, Ferrick KJ, Roth JA, et al. Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center experience). Am J Cardiol. 1993;72:1263–1267
  56. Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, et al. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation. 1995;92:3273–3281
  57. Kim SG. Implantable defibrillator therapy: does it really prolong life? How can we prove it?. Am J Cardiol. 1993;71:1213–1218
  58. Guarnieri T, Levine JH, Griffith LSC, Veltri EP. When sudden cardiac death is not so sudden (lessons learned from the automatic implantable defibrillator). Am Heart J. 1988;115:205–207
  59. Hochleitner M, Hortnagl H, Ng C, Hortnagl H, Gschnitzer F, Zechmann W. Usefulness of physiologic dual-chamber pacing in drug resistant idiopathic dilated cardiomyopathy. Am J Cardiol. 1990;66:198–202
  60. Auricchio A, Sommariva L, Salo RW, Scafuri A, Chiariello L. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease with shortened AV delay. Pacing Clin Electrophysiol. 1993;16:2034–2043
  61. Brecker SJD, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet. 1992;340:1308–1312
  62. Nishimura RA, Hayes DL, Holmes DR, Tajik AJ. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction (an acute Doppler and catheterization hemodynamic study). J Am Coll Cardiol. 1995;25:281–288
  63. Linde C, Gadler F, Edner M, Nordlander R, Rosenqvist M, Ryden L. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol. 1995;75:919–923
  64. Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure (a randomized study). J Am Coll Cardiol. 1995;26:967–973
  65. Shinbane JS, Chu E, DeMarco T, Sobol Y, Fitzpatrick AP, Lau DM, et al. Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure. J Am Coll Cardiol. 1997;30:1295–1300
  66. Kerwin WF, Botvinick EH, O’Connell MS, Merrick SH, DeMarco T, Chatterjee K, et al. Biventricular pacing in dilated cardiomyopathy (acute improvements in biventricular ejection fraction correspond with measures of improved RV/LV synchrony). (Abstr.) PACE Pacing Clin Electrophysiol. 1998;21:189
  67. Blanc JJ, Etienne Y, Gilard M, Mansourati J, Munier S, Boschat J, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure (results of an acute hemodynamic study). Circulation. 1997;96:3273–3277
  68. Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O, et al. Multisite pacing for end-stage heart failure (early experience). PACE Pacing Clin Electrophysiol. 1996;19:1748–1757
  69. Vigor-CHF Investigators Saxon LA, DeMarco T, Chatterjee K, Boehmer J. The magnitude of sympathoneural activation in advanced heart failure is altered with chronic biventricular pacing. (Abstr.) PACE Pacing Clin Electrophysiol. 1998;21:499
  70. MUSTIC study group Daubert C, Linde C, Cazeau S, Sutton R, Kappenberger L, Bailleul C. Protocol design of the MUSTIC (Multisite Stimulation in Cardiomyopathy) study. (Abstr.) Arch Mal Coeur Vaiss. 1998;91:154
  71. Lamp B, Hammel D, Kerber S, Deng M, Breithardt G, Block M. Multisite pacing in severe heart failure—how many patients are eligible?. (Abstr.) PACE Pacing Clin Electrophysiol. 1998;21:736

PII: S0002-9149(98)01016-9

American Journal of Cardiology
Volume 83, Issue 5, Supplement 2 , Pages 143-150 , 11 March 1999

Article Tools

* Image Usage & Resolution